Orbem raised €55.5M in a Series B round announced on January 20, 2026. German deeptech firm Orbem is using AI-powered MRI technology to scan biological samples in food, construction and medical environments.
German deeptech firm Orbem is using AI-powered MRI technology to scan biological samples in food, construction and medical environments.
Orbem, based in Berlin, Germany, announced €55.5M in Series B financing on January 20, 2026.
Participants include The Venture Collective, Supernova Invest, Innovation Industries, Possible Ventures, 83North, General Catalyst.
Orbital develops AI technology tailored to the specific requirements of real estate legal work, an area that has seen relatively limited coverage from broader legal technology platforms.
German company is a provider of targeted drug rescue program intended to involve pharmaceutical research and development.